The CNG is situated at the Génopole site in Evry, about 30 km south of Paris, where it has the benefit of a particularly favourable research environment through links with other laboratories on the same site: a campus for genomics research and biotechnology in France.
The Centre National de Génotypage (CNG) was created as a GIP (Public Interest Group) by the French Ministry of Research and New Technology. In October 1998, the CNG took over the genomic activities of the Généthon, which pioneered genetic studies in France with the support of the French Muscular Dystrophy Association. In 2002, the CNG became part of a new GIP, the Consortium National de Recherche en Génomique or CNRG.
